Uzbekistan COVID-19 Employer Resources

According to Sputnik news, the mass vaccination against COVID-19 is planned to begin in Uzbekistan in the first half of March; by the end of 2021, seven million people, or 20 percent of the population, can be vaccinated. 15 million doses of vaccines have been ordered on the world market. On February 17, the republican special commission for the fight against Coronavirus announced that the Uzbek authorities had certified the Russian Sputnik V vaccine for mass use in the country.

COVID-19 vaccine considerations for Uzbekistan

  • Can employers mandate the vaccine?
  • Who will control delivery of the vaccine?
    Federal government
  • Who covers the cost of the vaccine?
    Government and Employee
  • Where will people get vaccinated?
    Government designated vaccination locations
  • Is there cultural resistance to getting the vaccine?
    A little, because the COVID-19 vaccine is so new

Vaccination plan has been developed for the immunization of the country’s population, according to which 4.1 million people will be vaccinated in the first stage: people over 65 years old, medical workers, people with chronic diseases, teachers, kindergarten employees, law enforcement agencies. They will be vaccinated in state institutions and free of charge.

More Information

For Covid-19 information in Uzbeskistan  go to Sputnik News.  This information is only available in Russian.

This information is provided by GrECo Group, Asinta's partner in Uzbekistan.

Employee Benefits in Uzbekistan

Get insights on mandatory and common supplementary employee benefits in Uzbekistan.

Learn More

Top 6 Vaccine Considerations

Use our decision matrix to help support your employees.

Learn More

Page last modified: March 11, 2021

The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.